Plain-English translation of NCT06290869 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing two different smoking-cessation programs for people undergoing lung cancer screening. One program connects you to a national tobacco quitline for phone-based counseling and nicotine replacement therapy. The other offers phone-based counseling and nicotine replacement directly through your health system, with additional support if you haven't quit after three months.
Even though lung cancer screening guidelines recommend offering smoking-cessation treatment, many patients—especially those in underserved communities—don't receive it. This study aims to find the best way to deliver these treatments and remove barriers so more people can successfully quit smoking and reduce their lung cancer risk.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two smoking-cessation programs. Either you'll be referred to a national tobacco quitline that provides phone counseling, nicotine replacement, and online resources, or you'll receive phone-based counseling and nicotine replacement directly through your health system, with extra support at three months if needed. Both programs provide tools and support to help you quit smoking while you're undergoing lung cancer screening.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
United States
Phase
Large-scale testing
Sponsor
Georgetown University
Enrollment target
~1,188 participants
Started
February 2024
Primary completion
December 2027
Age range
50 Years – 80 Years
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Kathryn L Taylor, PhD
Georgetown University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.